Jones Jeffrey Alan

Insider profile

Performance

Overall performance
2.8

Performance over holding periods
2.8
30 days 90 days 120 days
Average return 0% 8.2% 15.1%
Success rate 78% 68% 82%
Transactions
11 0% Buy
34 71% Buy
47 69% Buy
Jones Jeffrey Alan's trades of Cullinan Therapeutics Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-02-25 2026-02-24 S Sale
49,665 -21.7%
181.10
US$4,992,800
49,665 -21.7% 181.10 US$4,992,800
2026-02-23 2026-02-20 S Sale
94,296 +26.4%
205.53
US$2,158,387
94,296 +26.4% 205.53 US$2,158,387
2025-12-19 2025-12-18 S Sale
20,780 +19.1%
306.97
US$3,412,092
20,780 +19.1% 306.97 US$3,412,092
2025-02-27 2025-02-25 S Sale
4,895 -2.7%
8.53
US$41,754
4,895 -2.7% 8.53 US$41,754
2024-12-20 2024-12-18 S Sale
4,632 -3.9%
11.41
US$52,851
4,632 -3.9% 11.41 US$52,851
2023-12-22 2023-12-21 S Sale
1,860 -3.2%
8.50
US$15,810
1,860 -3.2% 8.50 US$15,810
2023-12-20 2023-12-18 S Sale
386 -0.7%
8.22
US$3,173
386 -0.7% 8.22 US$3,173
2023-06-21 2023-06-20 S Sale
387 -0.7%
12.94
US$5,008
387 -0.7% 12.94 US$5,008
2023-05-19 2023-05-18 S Sale
394 -0.7%
8.76
US$3,451
394 -0.7% 8.76 US$3,451
2023-04-20 2023-04-18 S Sale
392 -0.7%
10.71
US$4,198
392 -0.7% 10.71 US$4,198
2023-03-27 2023-03-20 S Sale
390 -0.7%
11.32
US$4,415
390 -0.7% 11.32 US$4,415